FIGS

+ Watchlist + Portfolio

FIGS, Inc. Class A

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $14.49
52-Week Range: $6.50 – $17.48
Market Cap: $2.39B
P/E (TTM): 43.67
EPS (TTM): 0.33
Dividend Yield: —

Advanced Metrics

Price/Book: 5.58
PEG Ratio: —
Return on Equity: 14.76%
Return on Assets: 7.75%
Gross Margin: 68.91%
Operating Margin: 17.93%
Profit Margin: 8.72%
Current Ratio: 4.96
Debt/Equity: 0.13
Total Debt: $57.67M
Free Cash Flow: $78.62M
Revenue Growth: 28.80%
Earnings Growth: 275.00%
Enterprise Value: $2.16B

FIGS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$505.83M	$545.65M	$555.56M	$631.10M
Cost of Revenue	$151.38M	$168.68M	$179.94M	$211.26M
Gross Profit	$354.46M	$376.96M	$375.62M	$419.84M
Selling, General & Admin	$316.79M	$342.92M	$373.36M	$381.69M
Operating Expenses	$316.79M	$342.92M	$373.36M	$381.69M
Operating Income	$37.67M	$34.05M	$2.27M	$38.15M
EBITDA	$39.59M	$36.99M	$8.96M	$47.18M
Pretax Income	$38.73M	$40.81M	$14.34M	$47.21M
Income Tax	$17.54M	$18.17M	$11.62M	$12.96M
Net Income	$21.19M	$22.64M	$2.72M	$34.25M
Diluted EPS	0.11	0.12	0.02	0.19
Diluted Shares	187.55M	182.41M	180.10M	179.49M

FIGS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$159.78M	$144.17M	$85.64M	$81.98M
Receivables	$6.87M	$7.47M	$8.63M	$6.27M
Inventory	$177.98M	$119.04M	$115.76M	$127.97M
Current Assets	$356.50M	$385.66M	$382.77M	$447.29M
Total Assets	$395.06M	$473.21M	$509.79M	$580.00M
Current Liabilities	$71.39M	$57.29M	$90.14M	$90.52M
Total Debt	$19.16M	$47.11M	$53.03M	$60.00M
Total Liabilities	$87.33M	$96.36M	$132.66M	$142.53M
Retained Earnings	$39.12M	$61.75M	$64.47M	$98.72M
Shareholders' Equity	$307.74M	$376.85M	$377.13M	$437.46M
Working Capital	$285.11M	$328.37M	$292.62M	$356.76M

FIGS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$35.33M	$100.92M	$81.16M	$61.17M
Capital Expenditure	-$5.35M	-$16.35M	-$17.02M	-$8.17M
Free Cash Flow	-$40.68M	$84.57M	$64.14M	$53.00M
Depreciation & Amortisation	$1.92M	$2.94M	$6.69M	$9.04M
Stock-Based Compensation	$37.46M	$45.80M	$42.67M	$26.87M
Investing Cash Flow	-$5.85M	-$117.19M	-$94.92M	-$63.96M
Financing Cash Flow	$3.52M	$670.00K	-$44.77M	-$969.00K
Share Repurchases	$0.00	$0.00	-$45.45M	-$2.69M
Net Change in Cash	-$37.66M	-$15.60M	-$58.53M	-$3.76M

FIGS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$124.90M	$152.64M	$151.66M	$201.90M	$159.90M
Cost of Revenue	$40.44M	$50.39M	$45.59M	$74.83M	$51.60M
Gross Profit	$84.46M	$102.25M	$106.07M	$127.07M	$108.30M
Selling, General & Admin	$84.67M	$92.33M	$96.43M	$108.26M	$103.81M
Operating Expenses	$84.67M	$92.33M	$96.43M	$108.26M	$103.81M
Operating Income	-$211.00K	$9.91M	$9.63M	$18.81M	$4.48M
EBITDA	$1.79M	$12.07M	$11.96M	$21.36M	$7.89M
Pretax Income	$1.86M	$12.03M	$11.96M	$21.35M	$6.45M
Income Tax	$1.97M	$4.93M	$3.21M	$2.85M	$157.00K
Net Income	-$102.00K	$7.10M	$8.75M	$18.51M	$6.29M
Diluted EPS	0.00	0.04	0.05	0.10	0.03
Diluted Shares	162.47M	172.93M	180.88M	190.01M	196.09M

FIGS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$90.01M	$50.85M	$46.45M	$81.98M	$74.30M
Receivables	$6.55M	$9.13M	$12.22M	$6.27M	$5.24M
Inventory	$131.58M	$135.53M	$151.23M	$127.97M	$139.38M
Current Assets	$399.71M	$393.61M	$418.02M	$447.29M	$432.19M
Total Assets	$522.31M	$517.12M	$544.74M	$580.00M	$563.44M
Current Liabilities	$100.97M	$78.36M	$86.66M	$90.52M	$80.20M
Total Debt	$51.33M	$51.70M	$54.12M	$60.00M	$60.60M
Total Liabilities	$140.78M	$120.59M	$131.41M	$142.53M	$132.80M
Retained Earnings	$64.37M	$71.47M	$80.22M	$98.72M	$105.01M
Shareholders' Equity	$381.54M	$396.53M	$413.33M	$437.46M	$430.64M
Working Capital	$298.74M	$315.25M	$331.36M	$356.76M	$351.99M

FIGS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$9.23M	-$12.43M	$3.44M	$60.93M	-$3.20M
Capital Expenditure	-$1.31M	-$1.09M	-$2.91M	-$2.86M	-$2.42M
Free Cash Flow	$7.92M	-$13.52M	$531.00K	$58.06M	-$5.63M
Depreciation & Amortisation	$2.00M	$2.15M	$2.33M	$2.56M	$3.41M
Stock-Based Compensation	$7.24M	$7.62M	$6.83M	$5.19M	$5.45M
Investing Cash Flow	-$2.18M	-$26.91M	-$8.96M	-$25.90M	$13.80M
Financing Cash Flow	-$2.69M	$185.00K	$1.13M	$401.00K	-$18.26M
Share Repurchases	-$2.69M	$0.00	$0.00	$0.00	-$8.80M
Net Change in Cash	$4.36M	-$39.16M	-$4.39M	$35.43M	-$7.67M

Market Snapshot

About

FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle brand specializing in premium medical scrubs and related products. The company designs, manufactures, and sells antimicrobial, moisture-wicking scrubs and other medical apparel primarily targeting healthcare professionals. FIGS operates through an e-commerce platform and has built a strong brand presence among nurses, doctors, and other medical workers through social media and community engagement. The company has expanded beyond basic scrubs to include underscrubs, outerwear, compression socks, and lifestyle items. FIGS went public in 2021 and continues to grow its market share in the healthcare apparel industry through product innovation and direct relationships with healthcare workers.